Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Rotavirus Vaccine Co-administered with MR or MMR
NCT02153866Phase 4Unknown
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus infection. Status: unknown.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT02153866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153866.